Skip to Main Content

Paper Details

Identification of novel <i>MECOM</i> gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review.
Cold Spring Harb Mol Case Stud
2
2018
-, AML, CSF3R, CSF3R mutations, EIF4A2, MDS, MDS1 and ectopic viral integration site 1 complex, MECOM, MECOM gene fusion, RHD, RUNX1, SCN, Severe congenital neutropenia, acute myeloid leukemia, colony stimulating factor 3 receptor, colony stimulating factor 3 receptor (CSF3R) gene, congenital neutropenia, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, oncogenic targets, p, patient, patients, runt, runt homology domain, runt-related transcription factor 1, tyrosine, tyrosine kinase
Author NameAffiliation
Rajen ModyUniversity of Michigan Medical Center ann arbor
Yi-Mi WuMichigan Center for Translational Pathology, University of Michigan Medical Center ann arbor
Dan R RobinsonMichigan Center for Translational Pathology, University of Michigan Medical Center ann arbor
Robert J LonigroMichigan Center for Translational Pathology, University of Michigan Medical Center ann arbor
Pankaj VatsMichigan Center for Translational Pathology, University of Michigan Medical Center ann arbor
Pankaj VatsMichigan Center for Translational Pathology, University of Michigan Medical Center ann arbor
  • 1 - 6

Datasets

Release 1.2